Effects of Vitamin D Supplementation on Omentin-1 and Spexin Levels, Inflammatory Parameters, Lipid Profile, and Anthropometric Indices in Obese and Overweight Adults with Vitamin D Deficiency under Low-Calorie Diet: A Randomized Placebo Controlled Trial
Table 2
Comparison of the anthropometric index changes within and between groups after the intervention.
Placebo group1 (n = 25)
Vitamin D group2 (n = 30)
Baseline
End of the trial
Change
Baseline
End of the trial
Change
Weight (kg)
88.05 ± 13.32
84.10 ± 19.94
−3.95 ± 11
<0.001
86.33 ± 14
85.11 ± 13.06
−1.22 ± 2.2
<0.001
0.58
BMI (kg/m2)
32.16 ± 4.35
31.05 ± 4.48
−1.11 ± 0.95
<0.001
32.47 ± 4.05
31.06 ± 4.06
−1.41 ± 0.97
<0.001
0.7
Fat percent
39.77 ± 9.18
38.80 ± 9.52
−0.96 ± 1.81
0.04
40.91 ± 8
39.41 ± 8.44
−1.49 ± 1.97
0.03
0.7
Muscle percent
26.02 ± 5.85
26.56 ± 5.97
0.53 ± 1.30
0.3
26.87 ± 5.40
27.40 ± 5.56
0.73 ± 1.7
0.2
0.35
Waist circumference (cm)
115.89 ± 12
111.72 ± 11.9
−4.17 ± 1.61
<0.001
116 ± 10.56
112.3 ± 11.06
−3.66 ± 1.19
<0.001
0.52
Visceral fat
10.36 ± 3.20
10.08 ± 3.06
−0.27 ± 0.77
0.07
10.27 ± 3.37
10.23 ± 3.35
−0.48 ± 0.71
0.06
0.65
BMI: body mass index. 1Received placebo per day during 8 weeks. 2Received 2,000 IU vitamin D per day during 8 weeks. Significant difference (). Data are presented as means ± SDs. : comparison of within-group changes (paired-sample t-test). : comparison of between-group changes (independent t-test).
